Mohammad, K.A.; Naghi, A.H.; Ghatge, M.S.; Balogun, B.; Macias, M.; Roland, S.; Opare, A.; Abdulmalik, O.; Safo, M.K.; Omar, A.M.;
et al. Michael Acceptor Compounds as Hemoglobin Oxygen Affinity Modulators for Reversing Sickling of Red Blood Cells. Pharmaceuticals 2025, 18, 783.
https://doi.org/10.3390/ph18060783
AMA Style
Mohammad KA, Naghi AH, Ghatge MS, Balogun B, Macias M, Roland S, Opare A, Abdulmalik O, Safo MK, Omar AM,
et al. Michael Acceptor Compounds as Hemoglobin Oxygen Affinity Modulators for Reversing Sickling of Red Blood Cells. Pharmaceuticals. 2025; 18(6):783.
https://doi.org/10.3390/ph18060783
Chicago/Turabian Style
Mohammad, Khadijah A., Asala H. Naghi, Mohini S. Ghatge, Benita Balogun, Mariana Macias, Salma Roland, Albert Opare, Osheiza Abdulmalik, Martin K. Safo, Abdelsattar M. Omar,
and et al. 2025. "Michael Acceptor Compounds as Hemoglobin Oxygen Affinity Modulators for Reversing Sickling of Red Blood Cells" Pharmaceuticals 18, no. 6: 783.
https://doi.org/10.3390/ph18060783
APA Style
Mohammad, K. A., Naghi, A. H., Ghatge, M. S., Balogun, B., Macias, M., Roland, S., Opare, A., Abdulmalik, O., Safo, M. K., Omar, A. M., & El-Araby, M. E.
(2025). Michael Acceptor Compounds as Hemoglobin Oxygen Affinity Modulators for Reversing Sickling of Red Blood Cells. Pharmaceuticals, 18(6), 783.
https://doi.org/10.3390/ph18060783
